Recent advances in understanding synaptic abnormalities in Rett syndrome [version 1; referees: 2 approved]

Abstract

Rett syndrome is an extremely disabling X-linked nervous system disorder that mainly affects girls in early childhood and causes autism-like behavior, severe intellectual disability, seizures, sleep disturbances, autonomic instability, and other disorders due to mutations in the MeCP2 (methyl CpG-binding protein 2) transcription factor. The disorder targets synapses and synaptic plasticity and has been shown to disrupt the balance between glutamate excitatory synapses and GABAergic inhibitory synapses. In fact, it can be argued that Rett syndrome is primarily a disorder of synaptic plasticity and that agents that can correct this imbalance may have beneficial effects on brain development. This review briefly summarizes the link between disrupted synaptic plasticity mechanisms and Rett syndrome and early clinical trials that aim to target these abnormalities to improve the outcome for these severely disabled children.

Keywords

• Cell Signaling
• Congenital Heart Disease
• Control of Gene Expression
• Developmental & Pediatric Neurology
• Medical Genetics
• Neurodevelopment
• Neurogenetics
• Neuronal Signaling Mechanisms